These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6098235)

  • 1. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
    Jover B; Dupont M; Casellas D; Mimran A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
    Jover B; Mimran A
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):209S-214S. PubMed ID: 6099736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal adaptation to sodium deprivation. Effect of captopril in the rat.
    Mimran A; Jover B; Casellas D
    Am J Med; 1984 May; 76(5B):14-21. PubMed ID: 6328982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The renin-angiotensin system and renal adaptation to sodium restriction].
    Mimran A; Jover B; Dupont M; Casellas D
    Nephrologie; 1985; 6(3):127-31. PubMed ID: 3001555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sodium intake on physiological responses to angiotensin II in conscious dogs.
    Olsen ME; Meydrech EF
    Scand J Urol Nephrol Suppl; 1984; 79():29-34. PubMed ID: 6089315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
    Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM
    J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
    Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
    J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
    Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J
    J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.